VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ATHA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ATHAAthira Pharma, Inc.
$4.34$17M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksATHAQuarterly Financials

Athira Pharma, Inc. (ATHA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Athira Pharma, Inc. (ATHA) quarterly income statement — complete revenue, gross profit & net income history

ATHA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold067.4M243K200K243K00242K242K00000000000
COGS % of Revenue--------------------
Gross Profit0-67.4M-243K-200K-243K00-242K-242K00000000000
Gross Margin %--------------------
Gross Profit Growth %100%--17.36%-0.41%---------------
Operating Expenses18.14M11.16M6.63M7.09M9.29M15.57M29.62M27.79M27.45M29.01M35.04M31.64M29.77M32.93M24.13M23.57M23.39M18.78M17.83M16.64M
OpEx % of Revenue--------------------
Selling, General & Admin6.88M3.77M4.05M3.63M5.23M6.2M7.57M5.87M6.45M6.96M7.84M10.03M8.48M7.69M7.17M8.77M8.93M6.16M7.12M4.61M
SG&A % of Revenue--------------------
Research & Development11.26M6.96M2.58M3.66M4.3M9.37M17.92M21.91M20.99M23.68M27.2M21.61M21.29M15.24M16.96M14.8M14.46M12.62M10.71M12.02M
R&D % of Revenue--------------------
Other Operating Expenses0443K0-200K-243K01000K00-1000K0001000K000000
Operating Income-17.21M-78.56M-6.87M-7.29M-9.54M-15.57M-29.62M-28.03M-27.69M-29.01M-35.04M-31.64M-29.77M-32.93M-24.13M-23.57M-23.39M-18.78M-17.83M-16.64M
Operating Margin %--------------------
Operating Income Growth %-80.52%-404.72%76.79%73.99%65.56%46.35%15.47%11.42%7%11.88%-45.2%-34.24%-27.29%-75.35%-35.38%-41.67%-116.93%-106.83%-140.99%-638.77%
EBITDA-17.21M-79.12M-6.77M-7.09M-9.29M-15.32M-29.38M-27.79M-27.45M-28.77M-34.8M-31.4M-29.53M-32.69M-23.9M-23.35M-23.23M-18.65M-17.7M-16.52M
EBITDA Margin %--------------------
EBITDA Growth %-85.24%-416.32%76.97%74.48%66.14%46.74%15.58%11.5%7.07%11.99%-45.59%-34.47%-27.12%-75.25%-35.02%-41.34%-117.76%-142.2%-139.34%-633.69%
D&A (Non-Cash Add-back)0-551K108K200K243K243K243K242K242K245K244K244K236K239K231K221K154K126K123K118K
EBIT022.72M-6.61M-6.97M-9.14M-15.57M-25.49M-28.03M-27.69M-30.64M-35.04M-31.64M-29.61M-21.7M-21.17M-24.83M-21.15M-16.34M-15.75M-14.05M
Net Interest Income0-981K263K325K393K563K880K1.17M1.35M-221K2.07M00-173K987K493K173K103K73K74K
Interest Income0-981K263K325K393K563K880K1.17M1.35M1.73M2.07M000987K493K175K105K74K74K
Interest Expense0000000001.95M000173K002K2K1K0
Other Income/Expense-15.73M-4.32M263K325K393K563K880K1.17M1.35M1.73M2.07M2.04M1.95M2.79M3.94M-766K2.41M2.44M2.15M2.66M
Pretax Income-32.95M-82.89M-6.61M-6.97M-9.14M-15M-28.74M-26.86M-26.34M-27.29M-32.97M-29.6M-27.82M-30.14M-20.19M-24.34M-20.98M-16.34M-15.67M-13.97M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-32.95M-82.89M-6.61M-6.97M-9.14M-15M-28.74M-26.86M-26.34M-27.29M-32.97M-29.6M-27.82M-30.14M-20.19M-24.34M-20.98M-16.34M-15.67M-13.97M
Net Margin %--------------------
Net Income Growth %-260.36%-452.48%77%74.06%65.28%45.01%12.83%9.25%5.33%9.46%-63.31%-21.62%-32.6%-84.44%-28.81%-74.14%-136.63%-112.14%-85.36%-601.51%
Net Income (Continuing)-32.95M-82.89M-6.61M-6.97M-9.14M-15M-28.74M-26.86M-26.34M-27.29M-32.97M-29.6M-27.82M-30.14M-20.19M-24.34M-20.98M-16.34M-15.67M-13.97M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.73-18.94-1.68-1.78-2.30-3.90-7.50-7.00-6.90-7.20-8.70-7.80-6.80-6.80-4.30-6.50-4.90-4.40-4.20-3.80
EPS Growth %24.78%-385.64%77.6%74.57%66.67%45.83%13.79%10.26%-1.47%-5.88%-102.33%-20%-38.78%-54.55%-2.38%-71.05%-96%-83.33%-55.56%-521.93%
EPS (Basic)-1.73-18.94-1.68-1.78-2.30-3.90-7.50-7.00-6.90-7.20-8.70-7.80-6.80-6.80-4.30-6.50-4.90-4.40-4.20-3.80
Diluted Shares Outstanding19.03M4.28M3.94M3.91M3.9M3.85M3.85M3.84M3.83M3.81M3.81M3.8M3.79M3.78M3.78M3.77M3.76M3.74M3.73M3.72M
Basic Shares Outstanding19.03M4.28M3.94M3.91M3.9M3.85M3.85M3.84M3.83M3.81M3.81M3.8M3.79M3.78M3.78M3.77M3.76M3.74M3.73M3.72M
Dividend Payout Ratio--------------------